# Enovis Corporation (ENOV)

> Enovis Corporation (ENOV) trades at $27.68 (+0.14%) as of 7:30:07 PM EST on Nov 13, 2026, +43.05% over the past month. Market cap is $1.59B, with 7.3 days to cover in short interest.

Canonical: https://massive.com/quote/enov
Data as of: 2026-11-14T00:30:07.828Z (15-minute delayed)
Source: Massive (https://massive.com/docs/llms.txt)

## Price

**$27.68** +0.04 (+0.14%)
As of 7:30:07 PM EST on Nov 13, 2026 · 15-minute delayed
NYSE · usd

## Stock performance

How Enovis Corporation (ENOV) stock has performed from one day to one year, with its 52-week range.

| Period | Return |
| --- | --- |
| 1D | +0.14% |
| 1W | +1.91% |
| 1M | +43.05% |
| YTD | +3.90% |
| 1Y | -7.70% |
| 52-wk range | $16.70 – $31.67 |

From daily closes through Nov 13, 2026.

## Key statistics

Today's trading snapshot for ENOV: day range, open, previous close, volume and market cap.

| Measure | Value |
| --- | --- |
| Day range | $27.63 – $28.89 |
| Open | $28.65 |
| Prev close | $27.64 |
| Volume | 1.21M |
| Market cap | $1.59B |
| Shares out | 57.69M |

## Valuation and profitability ratios

Valuation and profitability ratios for Enovis Corporation: P/E, P/S, P/B, ROE and more.

| Measure | Value |
| --- | --- |
| P/E | — |
| P/S | 0.69 |
| P/B | 1.07 |
| P/FCF | 22.92 |
| ROE | -35.3% |
| ROA | -14.1% |
| Debt/Equity | 0.84 |
| Div yield | 0.00% |

As of Nov 12, 2026

## Insider trading

[Enovis Corporation (ENOV) insider trading](https://massive.com/quote/enov/insider-trading.md): open-market Form 4 buys and sells by Enovis Corporation insiders over the last 12 months.

## 8-K filings

Material corporate events Enovis Corporation has disclosed to the SEC on Form 8-K.

- Nov 5, 2026 · [Quarterly earnings](https://massive.com/quote/sec-filings/8-k/earnings-releases.md)
  “On November 5, 2026, the Company issued a press release reporting financial results for the third quarter ended October 2, 2026.”
- Sep 1, 2026 · Acquisition agreement
  “On August 31, 2026, Enovis Corporation (the "Company") entered into a binding offer to acquire eCential Robotics SAS ("eCential")... Under the terms of the agreement, the Company will acquire eCential based on an enterprise value of approximately €155,000,000, subject to certain adjustments, which corresponds to up-front consideration of approximately €176,000,000 in cash to be paid to eCential shareholders upon the closing of the acquisition, and, to the extent that certain milestones are achieved, up to an additional €35,000,000 in cash.”
- May 19, 2026 · Executive compensation change
  “The 2020 Plan Amendment (i) authorizes an additional 3,650,000 shares of the Company's common stock, par value $0.001 per share, for issuance under the 2020 Omnibus Incentive Plan and (ii) increases the maximum aggregate dollar value of equity-based awards and cash compensation that may be granted to any Outside Director from $350,000 to $750,000.”
- Dec 15, 2025 · Executive compensation change
  “During the Transition Period, Ms. Lang will continue to receive her current base salary for a period of six months, after which her base salary will be reduced by up to 50% for the remainder of the Transition Period. Ms. Lang will remain eligible to participate in the Company benefit plans in which she currently participates, including the Company's annual incentive plan.”
- Dec 10, 2025 · Credit facility
  “The Amended Credit Agreement provides for a revolving credit facility of up to $1.1 billion (the "Revolving Facility" and the loans thereunder, the "Revolving Loans") and a term loan facility of $700.0 million (the "Term Loan Facility" and the loans thereunder, the "Term Loans"). The Third Amendment extended the maturity date for all outstanding Revolving Loans and Term Loans to December 8, 2030.”

## ENOV short interest

How heavily ENOV is shorted: shares short, days to cover and average daily volume.

| Measure | Value |
| --- | --- |
| Days to cover | 7.3 |
| Short interest | 10.56M |
| Avg volume | 1.45M |

As of Oct 30, 2026 · reported to FINRA twice monthly.

## ENOV news

The latest news and headlines about Enovis Corporation (ENOV).

- [Enovis (ENOV) Q3 Earnings and Revenues Beat Estimates](https://www.zacks.com/stock/news/3023876/enovis-enov-q3-earnings-and-revenues-beat-estimates?cid=CS-ZC-FT-fundamental_analysis|yseop_template_4-3023876) · Zacks Investment Research · Nov 5, 2026 · neutral sentiment
- [Enovis to Host Second Quarter 2026 Results Conference Call on August 6th](https://www.globenewswire.com/news-release/2026/07/17/3329042/0/en/Enovis-to-Host-Second-Quarter-2026-Results-Conference-Call-on-August-6th.html) · GlobeNewswire Inc. · Jul 17, 2026 · neutral sentiment
- [4 Top Growth Stocks Worth Buying Under $100 Today](https://www.fool.com/investing/2026/07/03/4-top-growth-stocks-worth-buying-under-100-to/?source=iedfolrf0000001) · The Motley Fool · Jul 3, 2026 · positive sentiment
- [ront Street Bought 384K More Shares of Enovis in Q1. Is ENOV a Buy Now?](https://www.fool.com/coverage/filings/2026/05/22/ront-street-bought-384k-more-shares-of-enovis-in-q1-is-enov-a-buy-now/?source=iedfolrf0000001) · The Motley Fool · May 22, 2026 · neutral sentiment
- [Enovis to Host First Quarter 2026 Results Conference Call on May 7th](https://www.globenewswire.com/news-release/2026/04/10/3271695/0/en/Enovis-to-Host-First-Quarter-2026-Results-Conference-Call-on-May-7th.html) · GlobeNewswire Inc. · Apr 10, 2026 · positive sentiment

## About Enovis Corporation

Enovis Corp is a medical technology manufacturer and distributor of medical devices used in reconstructive surgery, rehabilitation, pain management, and physical therapy. Its products support patient care from injury prevention through post-surgical or post-injury rehabilitation and treatment of degenerative conditions. The company's reportable segments include Prevention & Recovery and Reconstructive segments. The majority of revenueis derived from the Prevention & Recovery segment, which includes products that are used by orthopedic specialists, primary care physicians, physical therapists, chiropractors, athletic trainers and other healthcare professionals to treat patients with musculoskeletal conditions resulting from degenerative diseases, deformitiesand sports-related injuries.

| Measure | Value |
| --- | --- |
| Exchange | NYSE |
| Market | stocks |
| Type | CS |
| Currency | USD |
| Industry | ORTHOPEDIC, PROSTHETIC & SURGICAL APPLIANCES & SUPPLIES |
| Employees | 7.8K |
| Listed | May 8, 2008 |

[Company website](https://www.enovis.com)

## FAQ

### What is the Enovis Corporation (ENOV) stock price today?

Enovis Corporation (ENOV) is trading at $27.68 (+0.14% on the day) as of 7:30:07 PM EST on Nov 13, 2026. Prices are delayed at least 15 minutes; real-time quotes are available from the Massive API.

### What is Enovis Corporation?

Enovis Corp is a medical technology manufacturer and distributor of medical devices used in reconstructive surgery, rehabilitation, pain management, and physical therapy.

### What is the short interest in ENOV?

As of Oct 30, 2026, ENOV has 10.56M shares short and 7.3 days to cover.

### What exchange is ENOV listed on?

Enovis Corporation (ENOV) trades on NYSE in USD, in the ORTHOPEDIC, PROSTHETIC & SURGICAL APPLIANCES & SUPPLIES industry.

## Live data

Prices here are 15-minute delayed. For real-time ENOV quotes and the full history behind this page, use the Massive API or MCP server:

- `GET https://api.massive.com/v3/snapshot?ticker.any_of=ENOV`

Requests need a Massive API key. API reference for agents: https://massive.com/docs/llms.txt. Connect an AI agent through the Massive MCP server: https://massive.com/docs/ai-tools.

## Related

- [Enovis Corporation (ENOV) insider trading](https://massive.com/quote/enov/insider-trading.md)
- [SEC 8-K events](https://massive.com/quote/sec-filings/8-k.md)
- [Markets overview](https://massive.com/quote/index.md)

Nothing here is investment advice. Data and content are provided for informational purposes under the Massive Terms of Service: https://massive.com/terms